Table 2 Prognostic assessment of the relative tumor-stroma cell subpopulation
Feature | Beta | HR (95% CI) | Wald | p value | Corrected p |
|---|---|---|---|---|---|
T cells | − 0.96 | 0.38 (0.207–0.703) | 9.54 | 0.002 | 0.01 |
CD8 T cells | -0.06 | 0.94 (0.823–1.084) | 0.66 | 0.415 | 0.415 |
Cytotoxic lymphocytes | − 1.78 | 0.17 (0.066–0.426) | 14.07 | 0.00018 | 0.002 |
B lineage | − 0.57 | 0.57 (0.357–0.895) | 5.93 | 0.015 | 0.037 |
NK cells | − 0.86 | 0.42 (0.206–0.875) | 5.39 | 0.02 | 0.04 |
Monocytic lineage | − 0.75 | 0.47 (0.160–1.393) | 1.85 | 0.174 | 0.222 |
Myeloid dendritic cells | − 0.90 | 0.41 (0.218–0.755) | 8.09 | 0.0045 | 0.015 |
Neutrophils | − 2.26 | 0.10 (0.012–0.898) | 4.23 | 0.04 | 0.066 |
Endothelial cells | − 0.82 | 0.44 (0.107–1.810) | 1.3 | 0.255 | 0.283 |
Fibroblasts | − 1.07 | 0.34 (0.072–1.625) | 1.82 | 0.177 | 0.222 |